122 related articles for article (PubMed ID: 905575)
1. Effect of furosemide on urinary excretion of prostaglandin E in normal volunteers and patients with essential hypertension.
Abe K; Yasujima M; Chiba S; Irokawa N; Ito T; Yoshinaga K; Saito T
Prostaglandins; 1977 Sep; 14(3):513-21. PubMed ID: 905575
[TBL] [Abstract][Full Text] [Related]
2. Implication of renal prostaglandin E in urinary sodium excretion.
Yasujima M; Abe K; Chiba S; Sato M; Irokawa N; Seino M; Imai Y; Saito K; Sakurai Y; Ito T; Haruyama T; Ritsu K; Yoshinaga K
Jpn Circ J; 1978 May; 42(5):565-9. PubMed ID: 702774
[TBL] [Abstract][Full Text] [Related]
3. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
[TBL] [Abstract][Full Text] [Related]
4. Effect of triamterene on urinary excretion of immunoreactive prostaglandin E in essential hypertension.
Chiba S; Abe K; Yasujima M; Irokawa N; Saito K; Sakurai Y; Ito T; Sato M; Otsuka Y; Yoshinaga K
Tohoku J Exp Med; 1979 Nov; 129(3):249-56. PubMed ID: 524352
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of prostaglandin E following the administration of furosemide and indomethacin to sick low-birth-weight infants.
Friedman Z; Demers LM; Marks KH; Uhrmann S; Maisels MJ
J Pediatr; 1978 Sep; 93(3):512-5. PubMed ID: 690780
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin excretion after furosemide in normal and low-renin essential hypertension.
Scherer B; Witzgall H; Weber PC
Klin Wochenschr; 1984 Aug; 62(16):777-82. PubMed ID: 6384651
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of prostaglandin E like material and kallikrein: effects of furosemide.
Halushka PV; Margolius HS; Allen H; Conradi EC
Prostaglandins; 1979 Sep; 18(3):359-68. PubMed ID: 260996
[TBL] [Abstract][Full Text] [Related]
8. Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension.
Seino M; Abe K; Irokawa N; Ito T; Yasujima M; Sakurai Y; Chiba S; Saito K; Ritz K; Kusaka T; Miyazaki S; Yoshinaga K
Tohoku J Exp Med; 1978 Mar; 124(3):197-203. PubMed ID: 635897
[TBL] [Abstract][Full Text] [Related]
9. Role of angiotensin II in renal prostaglandin E2 production after furosemide administration.
Fujimura A; Ebihara A
Hypertension; 1988 May; 11(5):491-4. PubMed ID: 3284821
[TBL] [Abstract][Full Text] [Related]
10. Furosemide-induced alterations in the electrolyte status, the function of renin-angiotensin-aldosterone system, and the urinary excretion of prostaglandins in newborn infants.
Sulyok E; Varga F; Németh M; Tényi I; Csaba IF; Ertl T; Györy E
Pediatr Res; 1980 May; 14(5):765-8. PubMed ID: 6992087
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E synthesis in the kidney in renin subgroups of essential hypertension.
Sato K; Abe K; Sato M; Haruyama T; Yasujima M; Hiwatari M; Tajima J; Kasai Y; Chiba S; Seino M; Yoshinaga K
Prostaglandins Leukot Med; 1982 Nov; 9(5):577-85. PubMed ID: 6757970
[TBL] [Abstract][Full Text] [Related]
12. The effect of propranolol on urinary prostaglandin E2 after frusemide administration in healthy subjects.
Fujimura A; Kajiyama H; Ebihara A
Eur J Clin Pharmacol; 1987; 31(5):605-7. PubMed ID: 3549322
[TBL] [Abstract][Full Text] [Related]
13. Effects of indomethacin on furosemide-stimulated urinary PGE2 excretion in man.
Brater DC; Beck JM; Adams BV; Campbell WB
Eur J Pharmacol; 1980 Jul; 65(2-3):213-9. PubMed ID: 7398787
[TBL] [Abstract][Full Text] [Related]
14. Effects of 1-Sar-8-Ile-angiotensin II on urinary prostaglandin excretion in patients with essential hypertension.
Yasujima M; Abe K; Otsuka Y; Chiba S; Ritsu K; Irokawa N; Seino M; Sakurai Y; Saito K; Ito T; Yoshinaga K
Tohoku J Exp Med; 1977 Nov; 123(3):271-8. PubMed ID: 601775
[TBL] [Abstract][Full Text] [Related]
15. [Reduced urinary prostaglandin E2-excretion and diminished responsiveness of plasma renin activity in patients with essential hypertension (author's transl)].
Scherer B; Held E; Lange HH; Weber PC
Klin Wochenschr; 1979 Jun; 57(11):567-73. PubMed ID: 459371
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic and endocrine responses of the kidney to frusemide in mild essential hypertension.
Mackay IG; Nath K; Cumming AD; Muir AL; Watson ML
Clin Sci (Lond); 1985 Feb; 68(2):159-64. PubMed ID: 3881208
[TBL] [Abstract][Full Text] [Related]
17. Suppression of plasma renin activity by indomethacin in man.
Frölich JC; Hollifield JW; Dormois JC; Frölich BL; Seyberth H; Michelakis AM; Oates JA
Circ Res; 1976 Sep; 39(3):447-52. PubMed ID: 821675
[TBL] [Abstract][Full Text] [Related]
18. Urinary prostaglandin and sodium metabolism in patients with essential hypertension.
Yasujima N; Abe K; Irokawa N; Chiba S; Sato M; Seino M; Sakurai Y; Saito K; Ito T; Ritsu K; Yoshinaga K
Tohoku J Exp Med; 1978 Mar; 124(3):277-83. PubMed ID: 635902
[TBL] [Abstract][Full Text] [Related]
19. Effect of furosemide on renal prostaglandins E2 and F2 alpha in normal subjects and in patients with essential hypertension.
Rathaus M; Bauminger S; Bernheim J
Isr J Med Sci; 1980 Feb; 16(2):106-10. PubMed ID: 7364563
[TBL] [Abstract][Full Text] [Related]
20. The role of renal prostaglandin E and kallikrein in pathogenesis of essential hypertension.
Abe K; Yasujima M; Sakurai Y; Chiba S; Itoh T; Imai Y; Sato M; Haruyama T; Omata K; Goto T; Sato K; Hiwatari M; Otsuka Y; Yoshinaga K
Jpn Circ J; 1979 Dec; 43(12):1105-16. PubMed ID: 396385
[No Abstract] [Full Text] [Related]
[Next] [New Search]
